产品: | HEPACAM 抗体 |
货号: | DF12075 |
描述: | Rabbit polyclonal antibody to HEPACAM |
应用: | WB IHC |
文献验证: | WB |
反应: | Human, Mouse, Rat |
预测: | Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog |
蛋白号: | Q14CZ8 |
RRID: | AB_2844880 |
产品描述
来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
HEPACAM Antibody detects endogenous levels of total HEPACAM.
RRID:
AB_2844880
引用格式: Affinity Biosciences Cat# DF12075, RRID:AB_2844880.
引用格式: Affinity Biosciences Cat# DF12075, RRID:AB_2844880.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:
展开/折叠
FLJ25530; GlialCAM; HECAM_HUMAN; HEPACAM; Hepatocyte cell adhesion molecule; Protein hepaCAM;
抗原和靶标
免疫原:
A synthesized peptide derived from human HEPACAM, corresponding to a region within C-terminal amino acids.
基因/基因ID:
文献引用
1). Astroglial exosome HepaCAM signaling and ApoE antagonization coordinates early postnatal cortical pyramidal neuronal axon growth and dendritic spine formation. Nature communications, 2023
(PubMed: 37620511)
[IF=16.6]
Application: WB Species: Mouse Sample:
Fig. 2 Involvement of A-Exo. surface signals in promoting axon growth and identification of the surface expression of HepaCAM (GlialCAM) on A-Exo. Representative images (a) and quantification (b) of axon length of cortical neurons in control (i) or treated with proteinase K (10 μg/ml, 5 min) digested A-Exo. (ii) sonicated (30 s) and proteinase K digested A-Exo. (iii) A-Exo. (iv) sonicated A-Exo. (v) or sonicated (30 s) and RNase (10 μg/ml, 5 min) digested A-Exo. (vi) 1 μg A-Exo./sample was used in each treatment in (a, b). White arrows: elongated axons; Number of neurons quantified in each group shown in the graph (6–11 neurons/replicate, 3 biological replicates)/group; Scale bar: 100 μm; Representative images (c) and quantification (d) of axon length of cortical neurons plated on either poly-D-lysine (PDL) coated or PDL/A-Exo. coated coverslips. Number of neurons quantified in each group shown in the graph (10–11 neurons/replicate, 3 biological replicates)/group; Scale bar: 100 μm; e Quantification of axon length of cortical neurons following A-Exo. treatment or co-treatment with A-Exo. and dynasore (dynamin inhibitor, 50 μM). n = 22 (control) or 21 (A-Exo. and A-Exo. + dynasore) neurons (6–7 neurons/replicate, 3 biological replicates)/group; f Proteomic identification of different categories of transmembrane proteins on A-Exo. surface. Specific transmembrane proteins are included in Supplementary Table 1. n = 3 biological replicates; g Detection of specific HepaCAM immunoreactivity (>5 replicates) from spinal cord lysate (10 μg/lane), astrocyte lysate (10 μg/lane), and A-Exo. (1 μg/lane) prepared from WT (+/+), HepaCAM heterozygous (+/−), and HepaCAM KO (−/−) mice; Red arrow: specific HepaCAM immunoreactivity; Black arrow: non-specific immunoreactivity; h Detection of specific HepaCAM immunoreactivity (>5 replicates) in A-Exo. but not in exosome-free ACM fractions; 1 μg A-Exo. was used in each experiment. p value in (d) determined from two-tailed t-test; p values in (b, e) determined by one-way ANOVA followed by post hoc Tukey’s test. Data are presented as mean values ± SEM.
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.